{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:50:00Z","timestamp":1794743400622,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-83917-z","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T17:10:18Z","timestamp":1736788218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Substituted piperazine conjugated to quinoline-thiosemicarbazide as potent \u03b1-glucosidase inhibitors to target hyperglycemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Mehran","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Eftekharian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Mojtabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Faramarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Iraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"4","key":"83917_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4103\/ajm.ajm_53_20","volume":"10","author":"MZ Banday","year":"2020","unstructured":"Banday, M. Z., Sameer, A. S. & Nissar, S. Pathophysiology of diabetes: an overview. Avicenna J. Med. 10 (4), 174\u2013188 (2020).","journal-title":"Avicenna J. Med."},{"key":"83917_CR2","doi-asserted-by":"crossref","unstructured":"Antar, S. A. et al. Diabetes mellitus: Classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed. Pharmacother. 168,  115734 (2023).","DOI":"10.1016\/j.biopha.2023.115734"},{"issue":"7","key":"83917_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","volume":"16","author":"DL Eizirik","year":"2020","unstructured":"Eizirik, D. L., Pasquali, L. & Cnop, M. Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat. Rev. Endocrinol. 16 (7), 349\u2013362 (2020).","journal-title":"Nat. Reviews Endocrinol."},{"key":"83917_CR4","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia, U. et al. Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci. 21 (17). (2020).","DOI":"10.3390\/ijms21176275"},{"issue":"19","key":"83917_CR5","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1039\/D2RA00067A","volume":"12","author":"M Sohrabi","year":"2022","unstructured":"Sohrabi, M. et al. A review on \u03b1-glucosidase inhibitory activity of first row transition metal complexes: a futuristic strategy for treatment of type 2 diabetes. RSC Adv. 12 (19), 12011\u201312052 (2022).","journal-title":"RSC Adv."},{"key":"83917_CR6","doi-asserted-by":"publisher","first-page":"111738","DOI":"10.1016\/j.fct.2020.111738","volume":"145","author":"U Hossain","year":"2020","unstructured":"Hossain, U. et al. An overview on the role of bioactive \u03b1-glucosidase inhibitors in ameliorating diabetic complications. Food Chem. Toxicol. 145, 111738 (2020).","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"83917_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2337\/diacare.28.1.154","volume":"28","author":"FA van de Laar","year":"2005","unstructured":"van de Laar, F. A. et al. \u03b1-Glucosidase inhibitors for patients with type 2 diabetes: results from a cochrane systematic review and meta-analysis. Diabetes Care  28 (1), 154\u2013163 (2005).","journal-title":"Diabetes Care"},{"issue":"13","key":"83917_CR8","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.3390\/molecules29133043","volume":"29","author":"D Zolotareva","year":"2024","unstructured":"Zolotareva, D. et al. Morpholine, piperazine, and piperidine derivatives as antidiabetic agents. Molecules 29 (13), 3043 (2024).","journal-title":"Molecules"},{"issue":"28","key":"83917_CR9","doi-asserted-by":"publisher","first-page":"19243","DOI":"10.1039\/D3RA01790G","volume":"13","author":"S Safapoor","year":"2023","unstructured":"Safapoor, S. et al. Synthesis, ADMT prediction, and in vitro and in silico \u03b1-glucosidase inhibition evaluations of new quinoline\u2013quinazolinone\u2013thioacetamides. RSC Adv. 13 (28), 19243\u201319256 (2023).","journal-title":"RSC Adv."},{"key":"83917_CR10","doi-asserted-by":"publisher","first-page":"105385","DOI":"10.1016\/j.bioorg.2021.105385","volume":"116","author":"I Abbasi","year":"2021","unstructured":"Abbasi, I. et al. Isatin-hydrazide conjugates as potent \u03b1-amylase and \u03b1-glucosidase inhibitors: synthesis, structure and invitro evaluations. Bioorg. Chem. 116, 105385 (2021).","journal-title":"Bioorg. Chem."},{"issue":"1","key":"83917_CR11","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1038\/s41598-023-31080-2","volume":"13","author":"S Moghadam Farid","year":"2023","unstructured":"Moghadam Farid, S. et al. Synthesis and structure\u2013activity relationship studies of benzimidazole-thioquinoline derivatives as \u03b1-glucosidase inhibitors. Sci. Rep. 13 (1), 4392 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"83917_CR12","doi-asserted-by":"publisher","first-page":"14019","DOI":"10.1038\/s41598-022-18455-7","volume":"12","author":"M Noori","year":"2022","unstructured":"Noori, M. et al. Design, synthesis, and in silico studies of quinoline-based-benzo[d]imidazole bearing different acetamide derivatives as potent \u03b1-glucosidase inhibitors. Sci. Rep. 12 (1), 14019 (2022).","journal-title":"Sci. Rep."},{"issue":"1","key":"83917_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41598-023-50711-2","volume":"14","author":"MK Ghomi","year":"2024","unstructured":"Ghomi, M. K. et al. Synthesis, in vitro potency of inhibition, enzyme kinetics and in silico studies of quinoline-based \u03b1-glucosidase inhibitors. Sci. Rep. 14 (1), 501 (2024).","journal-title":"Sci. Rep."},{"key":"83917_CR14","doi-asserted-by":"publisher","first-page":"134560","DOI":"10.1016\/j.molstruc.2022.134560","volume":"1274","author":"SK Avula","year":"2023","unstructured":"Avula, S. K. et al. Synthesis of novel substituted quinoline derivatives as diabetics II inhibitors and along with their in-silico studies. J. Mol. Struct. 1274, 134560 (2023).","journal-title":"J. Mol. Struct."},{"key":"83917_CR15","doi-asserted-by":"publisher","first-page":"1074331","DOI":"10.3389\/fchem.2022.1074331","volume":"10","author":"OF Elebiju","year":"2022","unstructured":"Elebiju, O. F. et al. Recent advances in functionalized quinoline scaffolds and hybrids-exceptional pharmacophore in therapeutic medicine. Front. Chem. 10, 1074331 (2022).","journal-title":"Front. Chem."},{"issue":"4","key":"83917_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s13765-014-4156-3","volume":"57","author":"HW Lee","year":"2014","unstructured":"Lee, H. W., Yang, J. Y. & Lee, H. S. Quinoline-2-carboxylic acid isolated from ephedra pachyclada and its structural derivatives show inhibitory effects against \u03b1-glucosidase and \u03b1-amylase. J. Korean Soc. Appl. Biol. Chem. 57 (4), 441\u2013444 (2014).","journal-title":"J. Korean Soc. Appl. Biol. Chem."},{"issue":"18","key":"83917_CR17","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1016\/j.bmc.2019.07.035","volume":"27","author":"M Taha","year":"2019","unstructured":"Taha, M. et al. Synthesis of quinoline derivatives as diabetic II inhibitors and molecular docking studies. Bioorg. Med. Chem. 27 (18), 4081\u20134088 (2019).","journal-title":"Bioorg. Med. Chem."},{"key":"83917_CR18","doi-asserted-by":"publisher","first-page":"128922","DOI":"10.1016\/j.molstruc.2020.128922","volume":"1222","author":"F Rahim","year":"2020","unstructured":"Rahim, F. et al. Isatin based thiosemicarbazide derivatives as potential inhibitor of \u03b1-glucosidase, synthesis and their molecular docking study. J. Mol. Struct. 1222, 128922 (2020).","journal-title":"J. Mol. Struct."},{"key":"83917_CR19","doi-asserted-by":"publisher","first-page":"106739","DOI":"10.1016\/j.bioorg.2023.106739","volume":"139","author":"R Basri","year":"2023","unstructured":"Basri, R. et al. Synthesis, biological evaluation and molecular modelling of 3-Formyl-6-isopropylchromone derived thiosemicarbazones as \u03b1-glucosidase inhibitors. Bioorg. Chem. 139, 106739 (2023).","journal-title":"Bioorg. Chem."},{"key":"83917_CR20","doi-asserted-by":"publisher","first-page":"134931","DOI":"10.1016\/j.molstruc.2023.134931","volume":"1278","author":"E Saeedian Moghadam","year":"2023","unstructured":"Saeedian Moghadam, E. et al. Synthesis, bioactivity, and molecular docking of benzimidazole-2-carbamate derivatives as potent \u03b1-glucosidase inhibitors. J. Mol. Struct. 1278, 134931 (2023).","journal-title":"J. Mol. Struct."},{"key":"83917_CR21","doi-asserted-by":"publisher","first-page":"137714","DOI":"10.1016\/j.molstruc.2024.137714","volume":"1304","author":"M \u00d6zil","year":"2024","unstructured":"\u00d6zil, M. et al. Synthesis of benzimidazoles containing piperazine ring as potential therapeutic agents against diabetes mellitus and antioxidant activities. J. Mol. Struct. 1304, 137714 (2024).","journal-title":"J. Mol. Struct."},{"key":"83917_CR22","doi-asserted-by":"publisher","first-page":"140561","DOI":"10.1016\/j.molstruc.2024.140561","volume":"1323","author":"M Ghasemi","year":"2025","unstructured":"Ghasemi, M. et al. Quinoline-piperazine derivatives as potential \u03b1-glucosidase inhibitors: synthesis, biological evaluation, and in silico studies. J. Mol. Struct. 1323, 140561 (2025).","journal-title":"J. Mol. Struct."},{"issue":"1","key":"83917_CR23","doi-asserted-by":"publisher","first-page":"8647","DOI":"10.1038\/s41598-022-11771-y","volume":"12","author":"A Iraji","year":"2022","unstructured":"Iraji, A. et al. Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: a new class of \u03b1-glucosidase inhibitors. Sci. Rep. 12 (1), 8647 (2022).","journal-title":"Sci. Rep."},{"issue":"1","key":"83917_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41598-023-50395-8","volume":"14","author":"H Hamedifar","year":"2024","unstructured":"Hamedifar, H. et al. Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent \u03b1-glucosidase inhibitors; molecular dynamics, kinetic and structure\u2013activity relationship studies. Sci. Rep. 14 (1), 388 (2024).","journal-title":"Sci. Rep."},{"issue":"4","key":"83917_CR25","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s11030-021-10310-7","volume":"26","author":"A Nasli Esfahani","year":"2022","unstructured":"Nasli Esfahani, A. et al. Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as \u03b1-glycosidase inhibitors. Mol. Divers. 26 (4), 1995\u20132009 (2022).","journal-title":"Mol. Divers."},{"issue":"1","key":"83917_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13065-022-00848-4","volume":"16","author":"K Pedrood","year":"2022","unstructured":"Pedrood, K. et al. Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent \u03b1-glucosidase inhibitors. BMC Chem. 16 (1), 57 (2022).","journal-title":"BMC Chem."},{"key":"83917_CR27","doi-asserted-by":"publisher","first-page":"107106","DOI":"10.1016\/j.bioorg.2024.107106","volume":"144","author":"A Azmi","year":"2024","unstructured":"Azmi, A. et al. Alpha-glucosidase inhibitory and hypoglycemic effects of imidazole-bearing thioquinoline derivatives with different substituents: in silico, in vitro, and in vivo evaluations. Bioorg. Chem. 144, 107106 (2024).","journal-title":"Bioorg. Chem."},{"issue":"1","key":"83917_CR28","doi-asserted-by":"publisher","first-page":"17338","DOI":"10.1038\/s41598-024-68176-2","volume":"14","author":"M Asadi","year":"2024","unstructured":"Asadi, M. et al. Synthesis, \u03b1-glucosidase inhibitory activity, and molecular dynamic simulation of 6-chloro-2-methoxyacridine linked to triazole derivatives. Sci. Rep. 14 (1), 17338 (2024).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83917-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83917-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83917-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T17:10:22Z","timestamp":1736788222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83917-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["83917"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83917-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1871"}}